ArticleCancer chemotherapy and pharmacology2009

Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc-Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice.

Jianxia Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.